phenotype

NEUROINFLAMMATION

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about NEUROINFLAMMATION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

11422Connections

16Hypotheses

25Analyses

50Outgoing

50Incoming

4Experiments

20Debates

Summary

NEUROINFLAMMATION is a phenotype associated with neurodegeneration research. Key relationships include: activates, regulates, associated with. Associated with AD, ALS, ALZHEIMER. Connected to 2614 entities in the SciDEX knowledge graph.

View on Wiki →

No AI portrait yet

Wiki Pages (1)

Knowledge base pages for this entity

Canonical Page

Microglia in Chronic Neuroinflammation

cell · 1202 words

→

Pathway Diagram

graph TD
    subgraph Signaling["Signaling"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| NEURODEGENERATION["NEURODEGENERATION"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Als["Als"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Neuroinflammation_1["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Inflammation_2["Inflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"activates"| Autophagy["Autophagy"]
        CYTOKINES["CYTOKINES"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIAL_DYSFUNCTION["MITOCHONDRIAL DYSFUNCTION"] -->|"activates"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    subgraph Pathology["Pathology"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| NEURON["NEURON"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| TAU["TAU"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Neuroinflammation["Neuroinflammation"]
        NEUROINFLAMMATION["NEUROINFLAMMATION"] -->|"associated with"| Inflammation["Inflammation"]
        APOE["APOE"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MICROGLIA["MICROGLIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        APP["APP"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
        MITOCHONDRIA["MITOCHONDRIA"] -->|"associated with"| NEUROINFLAMMATION["NEUROINFLAMMATION"]
    end
    style NEUROINFLAMMATION fill:#5d4400,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0,font-weight:bold
    style NEURODEGENERATION fill:#5d4400,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style NEURON fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style TAU fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Als fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Neuroinflammation_1 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Inflammation_2 fill:#ef5350,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style Autophagy fill:#1b5e20,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APOE fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MICROGLIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style APP fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIA fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style CYTOKINES fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    style MITOCHONDRIAL_DYSFUNCTION fill:#4a1a6b,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0

Outgoing (4512)

Target	Relation	Type	Str
Stroke	activates	disease	1.00
Epilepsy	activates	disease	1.00
Alzheimer	treats	disease	1.00
Oxidative Stress	associated_with	pathway	1.00
Inflammation	regulates	disease	1.00
Alzheimer	activates	disease	1.00
Stroke	therapeutic_target	disease	1.00
Alzheimer	contributes_to	disease	1.00
Microrna	regulates	pathway	1.00
Neurodegeneration	biomarker_for	disease	1.00
Als	causes	disease	1.00
Als	associated_with	disease	1.00
Alzheimer	therapeutic_target	disease	1.00
MICROGLIA	causes	gene	1.00
Neurodegeneration	implicated_in	disease	1.00
Als	implicated_in	disease	1.00
Als	therapeutic_target	disease	1.00
Inflammation	interacts_with	disease	1.00
Alzheimer	associated_with	disease	1.00
Neurodegeneration	inhibits	disease	1.00
Inflammation	therapeutic_target	disease	1.00
Microrna	regulates	pathway	1.00
Alzheimer	causes	disease	1.00
Parkinson	implicated_in	disease	1.00
Neurodegeneration	implicated_in	disease	1.00
Dementia	therapeutic_target	disease	1.00
MICROGLIA	implicated_in	gene	1.00
Infection	activates	disease	1.00
MTOR	activates	gene	1.00
STROKE	associated_with	gene	1.00
neurodegeneration	causes	phenotype	1.00
Dementia	therapeutic_target	disease	1.00
Inflammation	causes	disease	1.00
Inflammation	contributes_to	disease	1.00
NEURON	associated_with	gene	1.00
Alzheimer	biomarker_for	disease	1.00
Alzheimer	treats	disease	1.00
TAU	associated_with	gene	1.00
Parkinson	inhibits	disease	1.00
Als	activates	disease	1.00
Neurodegeneration	activates	disease	1.00
Neuroinflammation	interacts_with	disease	1.00
NEURODEGENERATION	activates	phenotype	1.00
Synaptic Plasticity	activates	pathway	1.00
Als	biomarker_for	disease	1.00
Neurodegeneration	biomarker_for	disease	1.00
Neurodegeneration	causes	disease	1.00
Alzheimer	implicated_in	disease	1.00
Inflammation	implicated_in	disease	1.00
Neurodegeneration	regulates	disease	1.00

Incoming (6910)

Source	Relation	Type	Str
entities-microglia-in-neurodegeneration	involved_in	wiki	0.00
entities-complement-system	involved_in	wiki	0.00
NEURODEGENERATIVE DISEASES	therapeutic_target	gene	1.00
ALZHEIMER'S DISEASE	contributes_to	gene	1.00
NEURODEGENERATIVE DISEASES	regulates	gene	1.00
OXIDATIVE STRESS	therapeutic_target	gene	1.00
PARKIN	activates	gene	1.00
ASTROCYTES	regulates	gene	1.00
APP	activates	gene	1.00
ALZHEIMER'S DISEASE	contributes_to	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
ASTROCYTES	activates	gene	1.00
TAU	therapeutic_target	gene	1.00
INFLAMMATION	regulates	gene	1.00
NLRP3	activates	gene	1.00
GFAP	biomarker_for	gene	1.00
STING	activates	gene	1.00
GENES	therapeutic_target	gene	1.00
TREM2	therapeutic_target	gene	1.00
AKT	therapeutic_target	gene	1.00
TNF-Α	activates	gene	1.00
MICROGLIA	regulates	gene	1.00
MICROGLIA	inhibits	gene	1.00
MICROGLIA	inhibits	gene	1.00
INFLAMMATION	inhibits	gene	1.00
NEUROINFLAMMATION	inhibits	gene	1.00
NEUROINFLAMMATION	contributes_to	gene	1.00
NEUROINFLAMMATION	regulates	gene	1.00
NEURODEGENERATIVE DISEASES	regulates	gene	1.00
NEURODEGENERATION	therapeutic_target	gene	1.00
Als	associated_with	disease	1.00
ASTROCYTES	therapeutic_target	gene	1.00
Parkinson	associated_with	disease	1.00
GENES	regulates	gene	1.00
AMPK	activates	gene	1.00
DNA	activates	gene	1.00
APP	activates	gene	1.00
CGAS	activates	gene	1.00
TNF	activates	protein	1.00
GENES	activates	gene	1.00
PI3K	activates	gene	1.00
PI3K	therapeutic_target	gene	1.00
INFLAMMATION	therapeutic_target	gene	1.00
NEUROINFLAMMATION	associated_with	gene	1.00
IL-6	activates	gene	1.00
NEUROINFLAMMATION	therapeutic_target	gene	1.00
NRF2	activates	gene	1.00
NEUROINFLAMMATION	interacts_with	gene	1.00
INFLAMMATION	inhibits	gene	1.00
TAU	therapeutic_target	gene	1.00

Targeting Hypotheses (16)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43	0.824	neurodegeneration	What are the mechanisms by which gut mic
Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone	0.808	neurodegeneration	What are the precise temporal dynamics o
SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resil	0.778	neurodegeneration	How do gut microbiome-derived metabolite
Microglial Disease-Associated States: TREM2-Independent Path	0.710	neurodegeneration	Cell type vulnerability debate in Alzhei
TLR4/MyD88/NF-κB Axis Blockade to Interrupt LPS-Mediated Gut	0.703	neurodegeneration	How do gut microbiome-derived metabolite

AQP4 Dysregulation Promotes Neuroinflammation Through Impair	0.680	neurodegeneration	What are the specific molecular mechanis
Lactate/Pyruvate Ratio Dynamics in CSF as a Neuroinflammatio	0.665	translational neuroscience	Which metabolic biomarkers can distingui
NeuroD1-Mediated Astrocyte Reprogramming Attenuates Neuroinf	0.650	neurodegeneration	epigenetic reprogramming aging neurons
STING Antagonism Prevents Acute-to-Chronic Neuroinflammation	0.601	neuroinflammation	What molecular mechanisms drive the tran
Cardiovascular-Neuroinflammation Crosstalk Interruption	0.587	Alzheimer's disease	Neuroinflammation and microglial priming
Astrocyte cGAS/STING Activation Converts Protective into Des	0.580	neuroinflammation	How does chronic cGAS/STING activation d
Neuroinflammation-Driven TDP-43 Mislocalization via Microgli	0.580	neurodegeneration	How does APOE4 mechanistically increase
PINK1/PARK2-Mediated Mitophagy Enhancement for Neuroinflamma	0.571	Neuroinflammation	Immune atlas neuroinflammation analysis
Testosterone-Derived DHT Amplifies Microglial Androgen Recep	0.490	neuroinflammation	How do regional, age, and sex-dependent
Necroptosis-cGAS Feedforward Loop Converts TDP-43 Pathology	0.460	neuroinflammation	How does chronic cGAS/STING activation d
Age-related neuroinflammation mimics early Alzheimer's disea	0.362	Alzheimer's disease	Allen Mouse Brain Aging Atlas: cross-age

Mentioning Analyses (25)

Scientific analyses that reference this entity

Experiments (4)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Model	Status	Est. Cost
Cerebrovascular function analysis in CD2AP mutant mice	validation	Alzheimer's disease	0.900	mice	proposed	N/A
PGC-1α knockout analysis of PV+ interneuron maturation	validation	neurodevelopmental disorders	0.850	knockout mice	proposed	N/A
Cell-cell interaction analysis of perivascular-microglial crosstalk	exploratory	Alzheimer's disease	0.800	AD mouse models	proposed	N/A
PV+ interneuron subtype diversification analysis	exploratory	neurodevelopmental disorders	0.750	mouse cortical PV+ interneuron	proposed	N/A

Related Papers (7)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
Complement C1q-Targeted Microglial Membrane Camouflaged Nanolipid Carriers for S [PMID:41114949]	Ding YN, Li MQ, Ding PT, Wang P, Guan PP	Nano letters	2026	1
Systemic inflammation as a central player in the initiation and development of A [PMID:40841660]	Bayraktaroglu I, Ortí-Casañ N, Van Dam D	Immunity & ageing : I & A	2025	1
Cerium-doped Prussian blue biomimetic nanozyme as an amplified pyroptosis inhibi [PMID:40050873]	Ma J, Tian Y, Du C, Zhu Y, Huang W, Ding	Journal of nanobiotechnology	2025	1
Interactions between antidiabetes medications and heart-brain axis. [PMID:39639832]	Ong LT, Sia CH	Current opinion in endocrinolo	2025	1
The Molecular Mechanisms of Cognitive Dysfunction in Long COVID: A Narrative Rev [PMID:40507911]	Popa E, Popa AE, Poroch M, Poroch V, Ung	International journal of molec	2025	1
Air pollution, glymphatic impairment, and Alzheimer's disease. [PMID:37777345]	Hussain R, Graham U, Elder A, Nedergaard	Trends in neurosciences	2023	0
Molecular biomarkers for vascular cognitive impairment and dementia. [PMID:37957261]	Hosoki S, Hansra GK, Jayasena T, Poljak	Nature reviews. Neurology	2023	0

Debates (20)

Multi-agent debates referencing this entity

NEUROINFLAMMATION

Understanding Entity Pages

Summary

Wiki Pages (1)

Microglia in Chronic Neuroinflammation

Pathway Diagram

Outgoing (4512)

Incoming (6910)

Targeting Hypotheses (16)

Mentioning Analyses (25)

Clinical Trial Landscaping for Alzheimer's Disease Therapeutics

How does Alectinib, a kinase inhibitor, achieve high-affinity binding to complem

Blood-brain barrier tight junction disruption by neuroinflammatory cytokines

What molecular mechanisms mediate SPP1-induced microglial phagocytic activation

What molecular mechanisms drive the transition from acute to persistent neuroinf

Why is TYROBP deficiency neuroprotective when TYROBP is an adapter for multiple

What molecular mechanisms determine whether reactive astrocytes adopt neurotoxic

Why do TAM receptors protect against neuroinvasive viruses despite their known i

How do oligodendrocytes initiate neuroinflammation in PD when microglia are trad

How do B cells mechanistically orchestrate tolerance to AQP4 and prevent autoimm

Does reduced Prevotellaceae abundance cause PD pathology or result from it?

Do tau-containing vesicles exhibit unique surface glycosylation patterns that di

Why do clinical manifestations overlap despite distinct underlying etiologies in

How does SPI1 transcriptionally regulate C1QA and C1QC expression in atheroscler

Why do systemic anti-inflammatory drugs fail in AD despite cardiovascular effica

Can circadian interventions reverse microglial priming independent of sleep disr

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pa